Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

N. B. Volz, S. Stintzing, W. Zhang, D. Yang, Y. Ning, T. Wakatsuki, R. E. El-Khoueiry, J. E. Li, A. Kardosh, F. Loupakis, C. Cremolini, A. Falcone, S. J. Scherer, H. J. Lenz

Research output: Contribution to journal › Article › peer-review